Zanetti Gianpaolo, Paparella Stefano, Ferruti Mario, Gelosa Marco, Abed Davide, Rocco Francesco
Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy.
Arch Ital Urol Androl. 2010 Mar;82(1):43-4.
Percutaneous nephrolithotomy (PCNL), PCNL and Shock Wave Lithotripsy (SWL), SWL monotherapy and open surgery are nowadays the potential treatment alternatives for patients with staghorn stones. Several groups have proposed classification schemes to better define staghorn calculi dimensions taking into account size, morphology and composition of the stones. More recently the use of a CT imaging with three-dimensional reconstruction or of a coronal reconstruction of axial CT images was reported to obtain an accurate stone volume calculation. The difficulty in accurately assessing stone burden explains the wide range of reported stone-free rates for SWL monotherapy from 22 to 85%. A recent AUA guideline of the management of staghorn calculi stated that stone free rate is 78% for PCNL and 54% for SWL monotherapy and these values are similar to those reported in Segura guideline but the rate for combination treatment (PNL + SWL) is now lower (66% versus 81%) than in the previous guideline. This reduction is probably due to the fact that in the recent meta-analysis SWL was the last procedure and in the previous generally a sandwich therapy was performed with PCNL followed by a SWL and a secondary PCNL. Improved PCNL techniques with use offlexible nephroscopy and multitract PCNL allow to achieve complete stone clearance by PCNL alone. Complete removal of stone is crucial to eradicate infection and prevent further stone regrowth. Residual fragments may perpetuate postreatment infection and stone regrowth has been reported up to 78% in such patients after SWL monotherapy. In our previous experience (prior to 2000) we observed 45 pts with high burden stones: 31/45 pts (68%) underwent combined therapy PCNL and SWL with a successful rate of 65% (stone free and fragments < 4 mm). In our more recent experience ('03-'08) we treated 34 patients with high burden stones: we performed combined therapy PCNL and SWL in 11 pts (32%) with an overall success rate of 63%. PCNL was undertaken initially with the attempt to remove as much stone as possible with the aid offlexible nephroscopy and SWL was used only for residual stones because the passage, even of fragments < 4 mm, does not always occur in dilated renal cavities. SWL monotherapy should not be used for most patients and may be considered only in patients with small volume staghorn stones with normal collecting system.
经皮肾镜取石术(PCNL)、PCNL联合冲击波碎石术(SWL)、单纯SWL治疗以及开放手术是目前鹿角形结石患者可能的治疗选择。多个研究小组提出了分类方案,以根据结石的大小、形态和成分更好地界定鹿角形结石的尺寸。最近有报道称,使用三维重建的CT成像或轴向CT图像的冠状重建来准确计算结石体积。准确评估结石负荷的困难解释了单纯SWL治疗报道的无石率范围很广,从22%到85%不等。美国泌尿外科学会(AUA)最近发布的鹿角形结石治疗指南指出,PCNL的无石率为78%,单纯SWL治疗的无石率为54%,这些数值与塞古拉指南中报道的相似,但联合治疗(PCNL+SWL)的比率现在(66%)低于先前指南中的比率(81%)。这种降低可能是因为在最近的荟萃分析中,SWL是最后进行的治疗,而在先前的治疗中,通常采用三明治疗法,即先进行PCNL,然后进行SWL,最后再进行一次PCNL。使用可弯曲肾镜和多通道PCNL的改良PCNL技术能够仅通过PCNL实现结石的完全清除。结石的完全清除对于根除感染和防止结石进一步复发至关重要。残留碎片可能导致治疗后感染持续存在,据报道,单纯SWL治疗后的此类患者结石复发率高达78%。根据我们之前的经验(2000年之前),我们观察了45例高负荷结石患者:其中31/45例(68%)接受了PCNL和SWL联合治疗,成功率为65%(无结石且碎片<4mm)。根据我们最近的经验(2003 - 2008年),我们治疗了34例高负荷结石患者:其中11例(32%)接受了PCNL和SWL联合治疗,总体成功率为63%。最初进行PCNL时,试图借助可弯曲肾镜尽可能多地清除结石,仅对残留结石使用SWL,因为即使是<4mm的碎片,在扩张的肾腔内也并非总能排出。大多数患者不应采用单纯SWL治疗,仅对于集合系统正常的小体积鹿角形结石患者可考虑使用。